CYMABAY THERAPEUTICS

CymaBay Therapeutics NASDAQ CBAY. CymaBay Therapeutics is a clinical-stage biopharmaceutical company developing breakthrough therapies addressing unmet medical needs. Arhalofenate, the companys lead product candidate, possesses two therapeutic actions in a single drug. In gout patients, arhalofenate is intended to prevent painful attacks in joints while at the same time promoting excretion of uric acid by the kidney, thereby removing the root cause of this debilitating disease. As of March 3, 2014.

OVERVIEW

This domain ir.cymabay.com currently has an average traffic ranking of zero (the smaller the more users). We have scanned eighteen pages within the domain ir.cymabay.com and found fifty-nine websites linking to ir.cymabay.com.
Pages Crawled
18
Links to this site
59

IR.CYMABAY.COM RANKINGS

This domain ir.cymabay.com has seen a variation amounts of traffic all round the year.
Traffic for ir.cymabay.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.cymabay.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.cymabay.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

CYMABAY THERAPEUTICS

At CymaBay, we are committed to improving the lives of patients with liver and other chronic diseases. By developing and providing access to innovative therapies. We are dedicated to enhancing the quality of healthcare by addressing the complex needs of patients, caregivers and communities and advancing medical knowledge.

WHAT DOES IR.CYMABAY.COM LOOK LIKE?

Desktop Screenshot of ir.cymabay.com Mobile Screenshot of ir.cymabay.com Tablet Screenshot of ir.cymabay.com

IR.CYMABAY.COM HOST

I identified that a single page on ir.cymabay.com took three thousand seven hundred and twenty-six milliseconds to download. I could not observe a SSL certificate, so our web crawlers consider this site not secure.
Load time
3.726 secs
SSL
NOT SECURE
Internet Protocol
107.23.183.25

SERVER OS

I observed that this domain is using the Apache/2.4.12 (Ubuntu) server.

PAGE TITLE

CYMABAY THERAPEUTICS

DESCRIPTION

CymaBay Therapeutics NASDAQ CBAY. CymaBay Therapeutics is a clinical-stage biopharmaceutical company developing breakthrough therapies addressing unmet medical needs. Arhalofenate, the companys lead product candidate, possesses two therapeutic actions in a single drug. In gout patients, arhalofenate is intended to prevent painful attacks in joints while at the same time promoting excretion of uric acid by the kidney, thereby removing the root cause of this debilitating disease. As of March 3, 2014.

CONTENT

This domain ir.cymabay.com has the following on the homepage, "CymaBay Therapeutics is a clinical-stage biopharmaceutical company developing breakthrough therapies addressing unmet medical needs." We analyzed that the webpage also said " Arhalofenate, the companys lead product candidate, possesses two therapeutic actions in a single drug." It also stated " In gout patients, arhalofenate is intended to prevent painful attacks in joints while at the same time promoting excretion of uric acid by the kidney, thereby removing the root cause of this debilitating disease. As of March 3, 2014."

SEEK OTHER DOMAINS

oLapislazulio The human beings eater - DeviantArt

Forgot Password or Username? The human beings eater.

Challenge Rimini, Triathlon sulla Riviera Adriatica

Domenica 24 maggio, 2015. Ospaly e Lehtonen sono i nuovi Campioni Europei half distance. Venerdì 1 maggio, 2015. Martedì 28 aprile, 2015. PER4M e GU nutrition sponsor di Challenge Rimini 2015. Una corretta nutrition strategy può essere la chiave per una gara di successo.

Blog de suicune997 - Blog de suicune997 - Skyrock.com

Voila maintenant que vous savez quoi faire.

Dyslexick - DeviantArt

Forgot Password or Username? Deviant for 6 Years. This is the place where you can personalize your profile! By moving, adding and personalizing widgets.